Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Read more
Catalent Biologics Adopts Berkeley Lights’ Beacon Optofluidic Platform To Accelerate Cell Line Development Read more
Symphogen A/S and Selexis Expand Relationship as Symphogen Advances its Monoclonal Antibody (mAb) Mixture Pipeline Read more
BioCryst Pharmaceuticals Announces Termination of Merger Agreement with Idera Pharmaceuticals Read more
ProBioGen and Pionyr Immunotherapeutics Initiate a Second Immuno-oncology Contract Development and Manufacturing Project Read more
International Stem Cell Corporation Expands Manufacturing Capabilities for Biomedical Products Read more